BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24067109)

  • 1. MicroRNA let-7f is down-regulated in patients with refractory acute myeloid leukemia and is involved in chemotherapy resistance of adriamycin-resistant leukemic cells.
    Dai CW; Bai QW; Zhang GS; Cao YX; Shen JK; Pei MF; Yin CC
    Leuk Lymphoma; 2014 Jul; 55(7):1645-8. PubMed ID: 24067109
    [No Abstract]   [Full Text] [Related]  

  • 2. Downregulation of microRNA let-7f mediated the Adriamycin resistance in leukemia cell line.
    Cao YX; Wen F; Luo ZY; Long XX; Luo C; Liao P; Li JJ
    J Cell Biochem; 2020 Oct; 121(10):4022-4033. PubMed ID: 31793054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letting microRNAs overcome resistance to chemotherapy in acute myeloid leukemia.
    Sakamoto KM
    Leuk Lymphoma; 2014 Jul; 55(7):1449-50. PubMed ID: 24206095
    [No Abstract]   [Full Text] [Related]  

  • 4. MicroRNA-103 confers the resistance to long-treatment of adriamycin to human leukemia cells by regulation of COP1.
    Wan L; Tian Y; Zhang R; Peng Z; Sun J; Zhang W
    J Cell Biochem; 2018 May; 119(5):3843-3852. PubMed ID: 29058777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
    Feng R; Dong L
    Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulated miR‑130a enhances the sensitivity of acute myeloid leukemia cells to Adriamycin.
    Liu H; Liu M; Zhang J; Liang Y
    Mol Med Rep; 2020 Oct; 22(4):2810-2816. PubMed ID: 32945422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous tumor necrosis factor and doxorubicin sensitivity in leukemic patients.
    Watanabe N
    Leuk Lymphoma; 1998 Aug; 30(5-6):477-82. PubMed ID: 9711910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.
    Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L
    Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1.
    Lu F; Zhang J; Ji M; Li P; Du Y; Wang H; Zang S; Ma D; Sun X; Ji C
    Int J Oncol; 2014 Jul; 45(1):383-92. PubMed ID: 24756163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of three different ATP-binding cassette transporters and correlation to chemoresistance in acute myeloid leukemia.
    Palaiologou D; Panayiotidis P; Papanikolaou G; Georgiou G; Boutsikas G; Hatzinicolaou SL; Pangalis GA; Sakellaropoulos N; Vassilakopoulos TP; Angelopoulou MK
    Int J Lab Hematol; 2015 Feb; 37(1):e7-e10. PubMed ID: 24809224
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of chemoresistance-related cell-surface glycoproteins in leukemia cells and functional validation of candidate glycoproteins.
    Sun Z; Dong J; Zhang S; Hu Z; Cheng K; Li K; Xu B; Ye M; Nie Y; Fan D; Zou H
    J Proteome Res; 2014 Mar; 13(3):1593-601. PubMed ID: 24467213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of mitochondrial ATPsyn-β in acute myeloid leukemia cells and with increased drug resistance.
    Xiao X; Yang J; Li R; Liu S; Xu Y; Zheng W; Yi Y; Luo Y; Gong F; Peng H; Pei M; Deng M; Zhang G
    PLoS One; 2013; 8(12):e83610. PubMed ID: 24391795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer.
    Xie M; Fu Z; Cao J; Liu Y; Wu J; Li Q; Chen Y
    Biomed Pharmacother; 2018 Jun; 102():286-294. PubMed ID: 29567542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring the gene expression profiles of doxorubicin-resistant acute myelocytic leukemia cells by DNA microarray analysis.
    Song JH; Choi CH; Yeom HJ; Hwang SY; Kim TS
    Life Sci; 2006 Jun; 79(2):193-202. PubMed ID: 16458935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via downregulation of MRP1 expression.
    Kweon SH; Song JH; Kim TS
    Biochem Biophys Res Commun; 2010 Apr; 395(1):104-10. PubMed ID: 20350534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for drug resistance related microRNAs in K562 and K562/A02 cell lines].
    Cao YX; Dai CW; Zhang GS
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):361-5. PubMed ID: 21122348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of CpG sites at the promoter region is associated with deregulation of mitochondrial ATPsyn-β and chemoresistance in acute myeloid leukemia.
    Yang J; Xiao X; Li R; Li Z; Deng M; Zhang G
    Cancer Biomark; 2016; 16(1):81-8. PubMed ID: 26835708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-16-1 Targeted Silences Far Upstream Element Binding Protein 1 to Advance the Chemosensitivity to Adriamycin in Gastric Cancer.
    Zhao D; Zhang Y; Song L
    Pathol Oncol Res; 2018 Jul; 24(3):483-488. PubMed ID: 28667493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism.
    Pan C; Wang X; Shi K; Zheng Y; Li J; Chen Y; Jin L; Pan Z
    PLoS One; 2016; 11(5):e0152090. PubMed ID: 27138141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells.
    Tian C; Zheng G; Zhuang H; Li X; Hu D; Zhu L; Wang T; You MJ; Zhang Y
    J Cell Physiol; 2017 Jun; 232(6):1387-1395. PubMed ID: 27696394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.